The Asia Pacific HIV Injection Market would witness market growth of 18.7% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific HIV Injection Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $172.7 Million by 2029. The Japan market is registering a CAGR of 17.9% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 19.4% during (2023 - 2030).
HIV injections are an important treatment option for people living with HIV, offering several advantages over oral medications, including improved adherence, reduced risk of drug interactions, and potentially higher efficacy. In recent years, the market has expanded substantially, propelled by the escalating the prevalence of HIV/AIDS and the rising need for efficacious treatment alternatives.
Injectable HIV medications offer several advantages over oral medications, including improved adherence, reduced pill burden, and potentially better long-term outcomes. As a result, the demand for injectable HIV medications has been steadily increasing, driving growth in the market. Regarding the management of HIV/AIDS, patient adherence and preference are critical, and injectable treatments contribute significantly to resolving these concerns.
The demand in the Asia Pacific is likely to be influenced by the high number of people living with HIV in the region, as well as the efforts of governments and organizations to expand access to HIV prevention, testing, treatment, and care. According to a report by the Organisation for Economic Co-operation and Development (OECD), Asia ranks second in the prevalence of individuals living with HIV, behind only sub-Saharan Africa. These factors will, consequently, bolster the development of the regional market.
Free Valuable Insights: The Global HIV Injection Market is Predict to reach USD 2.8 Billion by 2030, at a CAGR of 17.6%
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F.Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
Asia Pacific HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific HIV Injection Market, by Distribution Channel
1.4.2 Asia Pacific HIV Injection Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific HIV Injection Market by Distribution Channel
4.1 Asia Pacific Hospital Pharmacy Market by Country
4.2 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific HIV Injection Market by Country
5.1 China HIV Injection Market
5.1.1 China HIV Injection Market by Distribution Channel
5.2 Japan HIV Injection Market
5.2.1 Japan HIV Injection Market by Distribution Channel
5.3 India HIV Injection Market
5.3.1 India HIV Injection Market by Distribution Channel
5.4 South Korea HIV Injection Market
5.4.1 South Korea HIV Injection Market by Distribution Channel
5.5 Singapore HIV Injection Market
5.5.1 Singapore HIV Injection Market by Distribution Channel
5.6 Malaysia HIV Injection Market
5.6.1 Malaysia HIV Injection Market by Distribution Channel
5.7 Rest of Asia Pacific HIV Injection Market
5.7.1 Rest of Asia Pacific HIV Injection Market by Distribution Channel
Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.1 Gilead Sciences, Inc.
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.1.4 SWOT Analysis
6.2 ImmunityBio, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 SWOT Analysis
6.4 Theratechnologies Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Research & Development Expenses
6.4.4 SWOT Analysis
6.5 Viriom, Inc.
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Brii Biosciences Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 SWOT Analysis
6.8 Shionogi & Co., Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Expenses
6.8.4 SWOT Analysis
6.9 Boehringer Ingelheim International GmbH
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional & Segmental Analysis
6.9.4 Research & Development Expenses
6.9.5 SWOT Analysis
TABLE 1 Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 13 China HIV Injection Market, 2019 - 2022, USD Million
TABLE 14 China HIV Injection Market, 2023 - 2030, USD Million
TABLE 15 China HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 16 China HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 17 Japan HIV Injection Market, 2019 - 2022, USD Million
TABLE 18 Japan HIV Injection Market, 2023 - 2030, USD Million
TABLE 19 Japan HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 20 Japan HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 21 India HIV Injection Market, 2019 - 2022, USD Million
TABLE 22 India HIV Injection Market, 2023 - 2030, USD Million
TABLE 23 India HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 24 India HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 25 South Korea HIV Injection Market, 2019 - 2022, USD Million
TABLE 26 South Korea HIV Injection Market, 2023 - 2030, USD Million
TABLE 27 South Korea HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 South Korea HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Singapore HIV Injection Market, 2019 - 2022, USD Million
TABLE 30 Singapore HIV Injection Market, 2023 - 2030, USD Million
TABLE 31 Singapore HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 Singapore HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 Malaysia HIV Injection Market, 2019 - 2022, USD Million
TABLE 34 Malaysia HIV Injection Market, 2023 - 2030, USD Million
TABLE 35 Malaysia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Malaysia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Rest of Asia Pacific HIV Injection Market, 2019 - 2022, USD Million
TABLE 38 Rest of Asia Pacific HIV Injection Market, 2023 - 2030, USD Million
TABLE 39 Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Rest of Asia Pacific HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Key Information – GlaxoSmithKline PLC
TABLE 42 Key Information – Gilead Sciences, Inc.
TABLE 43 Key Information – ImmunityBio, Inc.
TABLE 44 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 45 Key Information – Theratechnologies Inc.
TABLE 46 Key Information – Viriom, Inc.
TABLE 47 Key information – AbbVie, Inc.
TABLE 48 Key Information – Brii Biosciences Limited
TABLE 49 Key Information – Shionogi & Co., Ltd.
TABLE 50 Key Information – Boehringer Ingelheim International GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific HIV Injection Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting HIV Injection Market
FIG 4 Porter’s Five Forces Analysis - HIV Injection Market
FIG 5 Asia Pacific HIV Injection Market share by Distribution Channel, 2022
FIG 6 Asia Pacific HIV Injection Market share by Distribution Channel, 2030
FIG 7 Asia Pacific HIV Injection Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Asia Pacific HIV Injection Market share by Country, 2022
FIG 9 Asia Pacific HIV Injection Market share by Country, 2030
FIG 10 Asia Pacific HIV Injection Market by Country, 2019 - 2030, USD Million
FIG 11 SWOT Analysis: GlaxoSmithKline PLC
FIG 12 SWOT Analysis: Gilead Sciences, Inc.
FIG 13 SWOT Analysis: ImmunityBio, Inc.
FIG 14 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 15 SWOT Analysis: Theratechnologies Inc.
FIG 16 SWOT Analysis: Viriom, Inc.
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Brii Biosciences Limited
FIG 19 SWOT Analysis: Shionogi & Co., Ltd.
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH